http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4675383-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc2a22a9271507062ad7e07974d3c58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-55
filingDate 1984-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e17b4eb5da3cff08e2d7ea92a70b376a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe8f00dbb4cc98dd88d0193887749d65
publicationDate 1987-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4675383-A
titleOfInvention Purification of T-cell growth factor
abstract Substantially homogenous T-cell growth factor is isolated. A multiple-step purification procedure of T-cell growth factor-containing biological sample includes at least one reverse-phase HPLC fractionation using a C3 to C5 silica gel stationary phase. A preferred pre-purification protocol includes concentration of the biological sample on a semipermeable medium followed by gel filtration and semi-preparative reverse-phase HPLC on a hydrophobic stationary phase. Fractionating the pre-purified biological sample with two or three reverse-phase HPLC fractionations using C3 to C5 silica gel stationary phase yields T-cells growth factor of over 90% purity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0366532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5902490-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4908433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6010633-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4908434-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5614185-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5417970-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7125492-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5359035-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5419899-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0368711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4730036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4925919-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4808151-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005011836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6015500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6251292-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9004406-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5472605-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9004642-A1
priorityDate 1983-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4406830-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4490289-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4401756-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4289690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4377482-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226607037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135845309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226540728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129021022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5833

Total number of triples: 47.